Literature DB >> 7856639

Psychosocial functioning in the Ehlers-Danlos syndrome.

M A Lumley1, M Jordan, R Rubenstein, P Tsipouras, M I Evans.   

Abstract

Ehlers-Danlos Syndrome (EDS) is a group of related genetic disorders of connective tissue presenting with joint hypermobility, skin extensibility, and tissue fragility. Although the pathophysiology of EDS is increasingly understood, the psychosocial effects of having EDS have not been examined. We psychologically tested and interviewed 41 adults and 7 children with EDS. Anxiety, depression, anger, and interpersonal concerns were significantly elevated, varying from one-quarter to one-third of patients; over 70% had a history of some mental health care use. Psychological difficulties appear to result from chronic pain and disability, ostracism or avoidance of relationships and social activities, sexual difficulties and reproductive concerns, and frustration with the medical system. Specific types of EDS (e.g., EDS Type I) are associated with greater pain and psychological distress. Psychological intervention, prescribed with the recognition that psychiatric features are secondary to EDS, is recommended for some patients.

Entities:  

Mesh:

Year:  1994        PMID: 7856639     DOI: 10.1002/ajmg.1320530206

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  16 in total

1.  Psychiatric disorders in Ehlers-Danlos syndrome are frequent, diverse and strongly associated with pain.

Authors:  Samantha Aliza Hershenfeld; Syed Wasim; Vanda McNiven; Manasi Parikh; Paula Majewski; Hanna Faghfoury; Joyce So
Journal:  Rheumatol Int       Date:  2015-10-03       Impact factor: 2.631

2.  Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients: comparison of psychosocial and health variables.

Authors:  Carolina Baeza-Velasco; Caroline Bourdon; Lucile Montalescot; Cécile de Cazotte; Guillem Pailhez; Antonio Bulbena; Claude Hamonet
Journal:  Rheumatol Int       Date:  2018-03-01       Impact factor: 2.631

Review 3.  Ehlers-Danlos syndrome and neurological features: a review.

Authors:  Salvatore Savasta; Pietro Merli; Martino Ruggieri; Lucia Bianchi; Maria Valentina Spartà
Journal:  Childs Nerv Syst       Date:  2010-08-10       Impact factor: 1.475

4.  Clearing the Air: A Qualitative Investigation of Genetic Counselors' Experiences of Counselor-Focused Patient Anger.

Authors:  Lynn Schema; Michaela McLaughlin; Patricia McCarthy Veach; Bonnie S LeRoy
Journal:  J Genet Couns       Date:  2015-02-05       Impact factor: 2.537

5.  Joint position sense and vibratory perception sense in patients with Ehlers-Danlos syndrome type III (hypermobility type).

Authors:  Lies Rombaut; Anne De Paepe; Fransiska Malfait; Ann Cools; Patrick Calders
Journal:  Clin Rheumatol       Date:  2009-11-25       Impact factor: 2.980

6.  Is pain the only symptom in patients with benign joint hypermobility syndrome?

Authors:  İlknur Albayrak; Halim Yilmaz; Halil Ekrem Akkurt; Ali Salli; Gülten Karaca
Journal:  Clin Rheumatol       Date:  2014-04-18       Impact factor: 2.980

7.  Unexpected association between joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type and obsessive-compulsive personality disorder.

Authors:  Massimo Pasquini; Claudia Celletti; Isabella Berardelli; Valentina Roselli; Simona Mastroeni; Marco Castori; Massimo Biondi; Filippo Camerota
Journal:  Rheumatol Int       Date:  2013-11-23       Impact factor: 2.631

8.  Self-reported quality of life, anxiety and depression in individuals with Ehlers-Danlos syndrome (EDS): a questionnaire study.

Authors:  Britta Berglund; Carina Pettersson; Maritta Pigg; Per Kristiansson
Journal:  BMC Musculoskelet Disord       Date:  2015-04-15       Impact factor: 2.362

Review 9.  Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

Authors:  Marco Castori; Nicol C Voermans
Journal:  Iran J Neurol       Date:  2014-10-06

10.  Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations.

Authors:  Marco Castori
Journal:  ISRN Dermatol       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.